Business
A Vaccine Against a Widespread Common Cold Type Just Passed Promising Clinical Trials – ScienceAlert
A vaccine designed to prevent one of the most widespread common cold types has just delivered promising results in the latest set of clinical trials, and the developers now think it could actually reach the market in just a few years.
A vaccine designed to prevent one of the most widespread common cold types has just delivered promising results in the latest set of clinical trials, and the developers now think it could actually reach the market in just a few years.
The cold, known as respiratory syncytial virus (RSV), is so common, more than 90 percent of kids contract it by the age of two. In fact, this dangerous and sometimes deadly infection is the leading cause of serious lower respiratory diseases in children worldwide…
-
Noosa News18 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General15 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General16 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel
-
General11 hours agoPerth man charged after investigation into organised crime and tobacco store attacks